The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...

GSK has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Arexvy (respiratory syncytial virus ...

The FDA approved the first vaccine for pregnant women to prevent RSV in infants. RSV is a disease that’s common in children. Severe RSV can require hospitalization, oxygen supplementation, and ...

The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...

GSK plc has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory ...

A vaccine for pregnant women, which can protect their infants from the RSV illness after birth, has been approved by the U.S. Food and Drug Administration. The FDA recently approved Abrysvo, a ...

In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...

Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation ...

New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...

GSK plc (GSK, GSK.L) said Japan's Ministry of Health, Labour and Welfare has approved Arexvy for the prevention of respiratory ...

Visiongain has published a new report entitled Anti-infective Vaccines Market Report 2023-2033: Forecasts by Vaccine Type (Seasonal Influenza Vaccine, Shingles, Tdap Containing /DTaP Primary Vaccine, ...